Psychedelic Science Newsletter
Issue #9November 3, 20257 studies

Saffron spice compound fixes ketamine's memory problems in teens

Saffron spice compound fixes ketamine's memory problems in teens

Monday, Monday, November 3rd Psychedelic Medicine Newsletter Issue #9

This week brought fascinating insights into how we might make psychedelic therapies safer and more effective, from teenage brains to cancer patients receiving treatment at home.

🧠 Saffron Spice Could Fix Ketamine's Memory Problems

Researchers gave adolescent female rats ketamine (a promising depression treatment) along with crocin, a compound from saffron spice, and found something remarkable:

  • Ketamine alone caused anxiety and memory problems while treating depression and pain

  • Adding crocin (30 mg/kg) completely flipped the script - it boosted ketamine's antidepressant and pain-relieving effects while eliminating the anxiety and memory issues

  • The combination essentially gave researchers the therapeutic benefits of ketamine without the concerning side effects

Why this matters: Ketamine shows promise for treating depression, especially in young people, but its side effects have been a major concern. This saffron compound could be the key to making ketamine therapy both safer and more effective for adolescents.

Top 50% journal 🔗 Behavioural Pharmacology 🗓️ Oct 26

Key Findings

🏠 First Home-Based Psilocybin Therapy for Cancer Patient

Doctors successfully treated a cancer patient with psilocybin therapy in their own home, marking a potential shift from clinical settings. The patient experienced significant improvements in psychospiritual distress, which affects many cancer patients and contributes to decreased survival and desire for hastened death.

💡 Psychedelic therapy might not need sterile clinical environments - home treatment could make it more accessible for seriously ill patients.
Top 30% journal 🔗 Palliative and Supportive Care 🗓️ Oct 22

🔬 MDMA Prevents Bone Loss Through Gut Bacteria

In a surprising finding, intermittent MDMA treatment prevented bone mineral density loss in mice that had their ovaries removed (mimicking menopause). The effect worked through what researchers call a "gut microbiota-bone axis" - MDMA changed gut bacteria in ways that protected bone health.

💡 MDMA's effects extend far beyond the brain - it might help prevent osteoporosis by changing gut bacteria.

📊 Psilocybin Safety Profile Looks Good Across 1,068 Patients

A systematic review of 42 clinical studies found that psilocybin has a favorable safety profile when used in controlled settings. Common side effects like headaches, temporary blood pressure increases, and nausea typically resolved on their own. Serious adverse events were rare, occurring in only 2 of 42 studies.

💡 Psilocybin appears remarkably safe in clinical settings - most side effects are mild and temporary.

🐟 Zebrafish Reveal Psychedelics Are Safe for Development

Researchers exposed zebrafish embryos and adults to various psychedelics including ayahuasca, DMT, LSD, MDMA, and psilocybin. Most psychedelics didn't cause developmental abnormalities, and many showed anxiety-reducing effects. Only ayahuasca caused problems at high concentrations.

💡 Psychedelics appear to have a safe developmental profile at therapeutic doses - important for understanding long-term safety.

💊 Ketamine Deaths Rising in Australia

Analysis of ketamine-related deaths in Australia from 2000-2025 revealed concerning trends as recreational ketamine use increases. The study examined population mortality rates and clinical characteristics of fatal ketamine poisoning cases to understand changing patterns of use and risk.

💡 As ketamine becomes more available for therapy, monitoring its recreational use and associated risks becomes critical.
Top 20% journal 🔗 Drug and Alcohol Review 🗓️ Oct 21

🧬 How Psychedelics Rewire Brains for Healing

A comprehensive review revealed that most psychedelics work through similar brain rewiring mechanisms - they activate serotonin receptors to stimulate BDNF signaling, which promotes new neural connections via the mTOR pathway. This neuroplasticity explains their effectiveness in depression, PTSD, and addiction.

💡 Psychedelics literally rewire the brain by growing new neural connections - that's why their effects last long after the drug wears off.

Implications

These studies paint a picture of psychedelic medicine rapidly maturing - from understanding how to make treatments safer with natural compounds like saffron, to expanding where therapy can happen, to mapping the brain mechanisms that make these treatments work. The field is moving from 'do they work?' to 'how can we make them work better and safer?'

Studies in this issue

Primary sources used for this newsletter.

  1. Ketamine and crocin affect anxiety, depression, memory, and pain in adolescent female rats
    main storyBehavioural pharmacology2025-10-27PMID 41144477
  2. Reporting and managing side effects in psilocybin therapy trials to improve clinical and research guidelines
    key findingProgress in neuro-psychopharmacology & biological psychiatry2025-10-25PMID 41138900
  3. Intermittent MDMA may reduce bone loss caused by ovariectomy through the gut microbiome.
    key findingClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2025-10-26PMID 41139601
  4. Rates and Features of Fatal Self-Poisoning with Ketamine in Australia, 2000–2025
    key findingDrug and alcohol review2025-10-22PMID 41121467
  5. Behavior and growth changes caused by psychedelics in zebrafish: a systematic review
    key findingProgress in neuro-psychopharmacology & biological psychiatry2025-10-22PMID 41125218
  6. Brain changes linked to psychedelic therapy for depression, PTSD, and addiction
    key findingProgress in neuro-psychopharmacology & biological psychiatry2025-10-23PMID 41130352
  7. Psilocybin therapy at home for a patient with advanced cancer: A case report
    key findingPalliative & supportive care2025-10-23PMID 41127918

Continue reading

All Psychedelic Science issues